Back to Corient Private Wealth LP Corient Private Wealth LP

IBRXIBRX
Showing 8 of 15 quarters

Position history for Corient Private Wealth LPCorient Private Wealth LP's holdings in IMMUNITYBIO INC

Corient Private Wealth LP holds 182,763 shares of IBRX (IMMUNITYBIO INC), worth $1.6M as of 2026-Q2. The position was decreased (-10.9% shares). IBRX represents 0.0% of Corient Private Wealth LP's portfolio.

Current Value

$1.6M

Current Shares

182,763

Total Value Change

-$58,580

Total Shares Change

-263,697

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
182,763
-10.9%
$1.6M0.0%$8.76
0
2026-Q1
Decreased
205,045
-60.5%
$1.5M0.0%$10.00
0
2025-Q4
Increased
519,524
+164.7%
$738,0480.0%$1.98
40
2025-Q3
Decreased
196,291
-4.5%
$482,8760.0%$2.57
0
2025-Q2
Decreased
205,595
-9.7%
$542,7710.0%$2.70
0
2025-Q1
Increased
227,668
+2.4%
$685,2810.0%$3.14
25
2024-Q4
Decreased
222,380
-50.2%
$569,2930.0%$2.68
0
2024-Q3
Increased
446,460
+101.0%
$1.7M0.0%$3.93
41

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used